INGREZZA Trademark

Trademark Overview

On Monday, October 15, 2018, a trademark application was filed for INGREZZA with the United States Patent and Trademark Office. The USPTO has given the INGREZZA trademark a serial number of 88155208. The federal status of this trademark filing is REGISTERED as of Tuesday, December 20, 2022. This trademark is owned by Neurocrine Biosciences, Inc.. The INGREZZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for movement disorders, namely, tardive dyskinesia; Pharmaceutical preparations for the treatment of neurological, central nervous system, and movement diseases and disorders; Pharmaceutical preparations for the treatment of tardive dyskinesia
ingrezza

General Information

Serial Number88155208
Word MarkINGREZZA
Filing DateMonday, October 15, 2018
Status700 - REGISTERED
Status DateTuesday, December 20, 2022
Registration Number6931307
Registration DateTuesday, December 20, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 17, 2019

Trademark Statements

Description of MarkThe mark consists of a sequence of right pointing arrows colored pink on the left shading into orange outlined with white lines and the word "INGREZZA" in black. The other white in the mark is background and is not claimed as a feature.
Goods and ServicesPharmaceutical preparations for human use for movement disorders, namely, tardive dyskinesia; Pharmaceutical preparations for the treatment of neurological, central nervous system, and movement diseases and disorders; Pharmaceutical preparations for the treatment of tardive dyskinesia
Indication of Colors claimedThe colors pink, orange, white, and black are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 25, 2018
Primary Code005
First Use Anywhere DateWednesday, April 26, 2017
First Use In Commerce DateWednesday, April 26, 2017

Trademark Owner History

Party NameNeurocrine Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameNeurocrine Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Tuesday, February 20, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 20, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 20, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 2, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 2, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 2, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 2, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 20, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 20, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, November 16, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 15, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, November 14, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, November 11, 2022USE AMENDMENT FILED
Friday, November 11, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, May 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 18, 2022SOU EXTENSION 5 GRANTED
Wednesday, May 11, 2022SOU EXTENSION 5 FILED
Wednesday, May 18, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 11, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 12, 2021SOU EXTENSION 4 GRANTED
Friday, November 12, 2021SOU EXTENSION 4 FILED
Friday, November 12, 2021SOU TEAS EXTENSION RECEIVED
Monday, May 24, 2021ASSIGNED TO EXAMINER
Tuesday, May 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 7, 2021SOU EXTENSION 3 GRANTED
Friday, May 7, 2021SOU EXTENSION 3 FILED
Friday, May 7, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, November 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 2, 2020SOU EXTENSION 2 GRANTED
Monday, November 2, 2020SOU EXTENSION 2 FILED
Monday, November 2, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, May 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 11, 2020SOU EXTENSION 1 GRANTED
Monday, May 11, 2020SOU EXTENSION 1 FILED
Monday, May 11, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, November 12, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 17, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 17, 2019PUBLISHED FOR OPPOSITION
Wednesday, August 28, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 15, 2019ASSIGNED TO LIE
Wednesday, August 7, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 31, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 30, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 30, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 17, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 17, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 31, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, January 31, 2019PRIORITY ACTION E-MAILED
Thursday, January 31, 2019PRIORITY ACTION WRITTEN
Thursday, January 24, 2019ASSIGNED TO EXAMINER
Friday, October 26, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, October 25, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 18, 2018NEW APPLICATION ENTERED

Related Keywords

ingrezza pharmaceutical preparations dyskinesia treatment tardive disorders movement system diseases nervous